Virtual Research & Development Event to be held on November 29 at 8:30 am. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on QURE:
- uniQure Highlights Therapeutic Potential of AMT-260 in Refractory Temporal Lobe Epilepsy (rTLE) at Virtual Research & Development Event
- uniQure to hold a virtual event
- QURE: The Most Expensive Treatment EVER Is Here
- uniQure announces FDA approval of first gene therapy for adults with hemophilia B
- uniQure Announces Multiple Presentations at the Upcoming Annual Meeting of The European Society of Gene and Cell Therapy (ESGCT)
